Sensenig Bethany
Insider CIK 1899935 · KALV Director · SUPN Director · NMTR Chief Financial Officer · ACOG Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 45,000 | — | $0 | 0 | SEC↗ |
| ACOG Alpha Cognition Inc. | A Award deriv | 2026-04-16 | 2026-04-17 | 6,991 | — | $0 | 6,991 | SEC↗ |
| ACOG Alpha Cognition Inc. | A Award | 2026-04-16 | 2026-04-17 | 5,489 | — | $0 | 5,489 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2026-02-19 | 2026-02-23 | 4,475 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2026-02-19 | 2026-02-23 | 4,475 | — | $0 | 4,475 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 3,258 | $51.27 | $167.0K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 1,217 | $50.31 | $61.2K | 3,258 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 4,977 | — | $0 | 4,977 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 2,989 | — | $0 | 2,989 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-08-14 | 2025-08-18 | 5,369 | $42.25 | $226.8K | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 5,369 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 7,296 | — | $0 | 7,296 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 4,475 | — | $0 | 4,475 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 5,369 | — | $0 | 5,369 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 8,252 | — | $0 | 8,252 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-08-17 | 2023-08-21 | 24,153 | — | $0 | 24,153 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | S Sale | 2023-04-21 | 2023-04-21 | 9,100 | $1.21 | $11.0K | 41,077 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award | 2023-03-27 | 2023-03-29 | 50,177 | — | $0 | 50,177 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2022-01-18 | 2022-01-18 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |